Strong Consumer Engagement and Loyalty
Evolus' consumer loyalty program grew to over 1.3 million members, a 34% increase year-on-year, with nearly 70% returning customers.
Evolysse Launch Success
Evolysse generated $5.7 million in revenue in the third quarter and $15.5 million since launch, marking the strongest HA filler debut in over a decade.
International Market Expansion
Evolus entered two new markets this year, with the U.K. showing a market share that closely mirrors U.S. post-launch performance.
Jeuveau Outperforms Market
Despite U.S. aesthetic market headwinds, Jeuveau unit volume has grown year-to-date, outperforming a market that is down single digits.
Revenue Growth
Third-quarter revenue increased by 13%, driven by strong global demand for Jeuveau and early contributions from Evolysse.
Positive Customer Expansion
Evolus added nearly 500 new purchasing accounts in the third quarter, bringing the total to over 17,000 accounts.
Regulatory Advancements
Submission of PMA to the U.S. FDA for Evolysse Sculpt and ongoing progress in other regulatory milestones.